Literature DB >> 15626473

Anatomy of a murder--signal transduction pathways leading to activation of natural killer cells.

S Zompi1, F Colucci.   

Abstract

Natural killer (NK) cells control the early phases of viral infections, modulate antigen-specific immune responses, and participate in the rejection of tumours and bone marrow grafts. A fine balance between inhibitory and activating receptors tightly regulates NK cell activation. Biochemical studies in human cell lines and primary cells have revealed some of the activating NK cell signalling pathways, however animal models are instrumental to understand the physiological implications of these findings for immune responses in vivo. Gene targeting in mice and biochemical studies in cells are helping to dissect out the various signal transduction pathways that control NK cell activation. A clearer view of these pathways may eventually help designing more effective immune therapies based on the use of NK cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15626473     DOI: 10.1016/j.imlet.2004.10.006

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  8 in total

1.  Differential activation of NK cells by influenza A pseudotype H5N1 and 1918 and 2009 pandemic H1N1 viruses.

Authors:  Ning Du; Jianfang Zhou; Xiaojing Lin; Yonghui Zhang; Xiaoxing Yang; Yue Wang; Yuelong Shu
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

2.  Allogenic natural killer cell immunotherapy of sizeable ovarian cancer: A case report.

Authors:  Silun Xie; Jibing Chen; Mingjiie Zhang; Zhengyi Wu
Journal:  Mol Clin Oncol       Date:  2017-04-28

3.  Bi-specific aptamers mediating tumor cell lysis.

Authors:  Achim Boltz; Birgit Piater; Lars Toleikis; Ralf Guenther; Harald Kolmar; Bjoern Hock
Journal:  J Biol Chem       Date:  2011-04-29       Impact factor: 5.157

Review 4.  Activation, coactivation, and costimulation of resting human natural killer cells.

Authors:  Yenan T Bryceson; Michael E March; Hans-Gustaf Ljunggren; Eric O Long
Journal:  Immunol Rev       Date:  2006-12       Impact factor: 12.988

5.  Kinome analysis of receptor-induced phosphorylation in human natural killer cells.

Authors:  Sebastian König; Manfred Nimtz; Maxi Scheiter; Hans-Gustaf Ljunggren; Yenan T Bryceson; Lothar Jänsch
Journal:  PLoS One       Date:  2012-01-04       Impact factor: 3.240

6.  Increasing the clinical efficacy of NK and antibody-mediated cancer immunotherapy: potential predictors of successful clinical outcome based on observations in high-risk neuroblastoma.

Authors:  Tony A Koehn; Lori L Trimble; Kory L Alderson; Amy K Erbe; Kimberly A McDowell; Bartosz Grzywacz; Jacquelyn A Hank; Paul M Sondel
Journal:  Front Pharmacol       Date:  2012-05-16       Impact factor: 5.810

Review 7.  Immune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodies.

Authors:  Ngoc Phuong Lan Le; Thomas A Bowden; Weston B Struwe; Max Crispin
Journal:  Biochim Biophys Acta       Date:  2016-04-20

8.  Gradual Increase of FcγRIIIa/CD16a Expression and Shift toward IFN-γ Secretion during Differentiation of CD56dim Natural Killer Cells.

Authors:  Laurie Lajoie; Nicolas Congy-Jolivet; Armelle Bolzec; Gilles Thibault
Journal:  Front Immunol       Date:  2017-11-20       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.